• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Acceleron Pharma Inc - Articles and news items


FDA Fast Track designation granted to luspatercept for the treatment of patients with beta-thalassemia

Industry news / 18 May 2015 / Victoria White

The FDA has granted Fast Track designations to luspatercept for two separate indications for the treatment of patients with beta-thalassemia…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +